Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

BACKGROUND: Nephrotic syndrome that is resistant to steroid therapy is termed refractory nephrotic syndrome (RNS), a condition that is associated with an increased risk of end-stage renal disease. Immunosuppressants are used to treat RNS; however, prolonged use may lead to significant adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zheyi, Zhou, Jianhui, Xu, Zhonggao, Ni, Zhaohui, He, Yani, Lin, Hongli, Jiang, Gengru, Sun, Xuefeng, Zhang, Li, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337463/
https://www.ncbi.nlm.nih.gov/pubmed/36990111
http://dx.doi.org/10.2196/46101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337463/
https://www.ncbi.nlm.nih.gov/pubmed/36990111
http://dx.doi.org/10.2196/46101

Ejemplares similares